Daniel Einhorn, M.D., F.A.C.P., .F.A.C.E.

2016 recipient of the John A. Seibel, MD, Award

Dr. Einhorn is a clinical endocrinologist with Diabetes and Endocrine Associates, Medical Director of the Scripps Whittier Diabetes Institute, and a Clinical Professor of Medicine at the University of California San Diego.

He received his Bachelor of Arts from Yale (Summa Cum Laude) and his medical degree from Tufts (Alpha Omega Alpha) before going on to training at the Beth Israel Hospital, Harvard Medical School. He did a residency in internal medicine, a year of psychiatry, and his Fellowship in endocrinology and metabolism at The Thorndike Labs before becoming an Instructor of Medicine at Harvard.

In 2005, Dr. Einhorn was the recipient of the Yank D. Coble, Jr., MD, Distinguished Service Award from the American College of Endocrinology (ACE). In 2006, he was elected Secretary of the American Association of Clinical Endocrinologists (AACE) and in subsequent years, elected as Treasurer, Vice President, President Elect and then President in 2010-2011.

 Dr. Einhorn was Co-Chair of the AACE/ACE Consensus Conference on the Insulin Resistance Syndrome (2003) and the Consensus Conference on Prediabetes (2008). He served as a task force member of the Consensus Conference on Obesity (2014) and Consensus Conference on Glucose Monitoring (2014).  He is past Chair of multiple committees and the original AACE 3000 Campaign. He is on the Board and Executive Committee of the California Chapter of AACE. He has presented at regional and national AACE meetings for nearly 20 years on subjects ranging from the evolving role of the clinical endocrinologist to clinical strategies, devices, and novel compounds. 

Dr. Einhorn was the Guest Editor of theEndocrinology and Metabolism Clinics of North Americafor “Type 2 Diabetes as a Cardiovascular Disease,” and The Royal Society Press’s “Type 2 Diabetes: Interpreting Results in a Time of Pandemic.”

He has served on the Endocrine Society’s (ES) Clinical Affairs Committee, American Diabetes Association (ADA) Managed Care Initiative, and is past Chair of the Diabetes and Pregnancy Program of San Diego and Imperial Counties. Dr. Einhorn was the endocrinologist representative on the American Medical Association’s (AMA) Diabetes Advisory Council and the current AMA website for diabetes management. He has Chaired Task Forces and Consensus Conferences for AACE/ACE, including the Insulin Resistance Syndrome and Prediabetes.

His research and publication interests include diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies and pharmaceuticals, combination therapies, and clinical decision-making. He has lectured nationally and internationally on these topics and has chaired meetings of the American Federation of Clinical Research in Carmel, TES Postgraduate Meetings in diabetes, and numerous regional symposia. He consults to and is on Advisory Boards of biotechnology and pharmaceutical companies, and is a reviewer forEndocrine Practice, AACE’s peer-reviewed medical journal,Diabetes Care,American Journal of Medicine,Journal of the American Medical Association,Journal of Endocrinology and Metabolism,  The Medical Letter, andDiabetes Health. Dr. Einhorn is an Associate Editor of theJournal of Diabetesand on the Editorial Board ofClinical Endocrinology News.He has been named one of San Diego’s Best Doctors every year the awards have been given.

Dr. Einhorn’s passions are his family, wife Emily, and children Max and Estee, and community service. He is a board member of a number of philanthropies, including a Trustee of the La Jolla Playhouse. He is especially interested in the education of children, preventive health care, and in the healing relationship.